Targeted suppression of type 1 interferon signaling during RNA delivery enhances vaccine-elicited immunity
Authors:
Preprint
Abstract
RNA vaccines have emerged as a breakthrough technology, and one promising modality employs alphavirus-derived self-replicating RNA (repRNA) to express vaccine antigens. However, both the lipid nanoparticles (LNP) commonly used to deliver RNA and virus-like amplification of repRNAs trigger innate immune recognition, especially via type I interferon (IFN) signaling. To modulate IFN responses during vaccination, we formulated LNPs co-delivering antigen-encoding RNA together with siRNA targeting the interferon-α/β receptor-1 (IFNAR1). siRNA-mediated repression of IFNAR1 increased antigen expression from repRNAs by >10-fold, increased immune cell infiltration, and increased antigen presenting cell activation in the injection site and draining lymph nodes. Compared to repRNA alone, siRNA/repRNA co-delivery increased serum antibody titers >10-fold, dramatically augmented antigen-specific germinal center (GC) B cell responses, and primed 4.4-fold more antigen-specific T cells. Ifnar1 silencing by siRNA co-delivery similarly enhanced mRNA vaccines. Thus, siRNA co-delivery is a readily translatable approach to substantially enhance the immunogenicity of RNA vaccines.Keywords
This publication has 56 references indexed in Scilit:
- Less is more: Self-amplifying mRNA becomes self-killing upon dose escalation in immune-competent retinal cellsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2024
- Optimization of storage conditions for lipid nanoparticle-formulated self-replicating RNA vaccinesJournal of Controlled Release, 2022
- Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message acrossAdvanced Drug Delivery Reviews, 2021
- The Opposing Effect of Type I IFN on the T Cell Response by Non-modified mRNA-Lipoplex Vaccines Is Determined by the Route of AdministrationMolecular Therapy Nucleic Acids, 2020
- Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects against Zika Virus InfectionMolecular Therapy - Methods & Clinical Development, 2020
- Expression Kinetics and Innate Immune Response after Electroporation and LNP-Mediated Delivery of a Self-Amplifying mRNA in the SkinMolecular Therapy Nucleic Acids, 2019
- Effects of cationic adjuvant formulation particle type, fluidity and immunomodulators on delivery and immunogenicity of saRNAJournal of Controlled Release, 2019
- Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of ImmunodominanceCell, 2019
- Type I Interferons Modulate CD8 + T Cell Immunity to mRNA VaccinesTrends in Molecular Medicine, 2017
- Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**Angewandte Chemie International Edition, 2012